- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04394364
Analysis and Record Intraoperative Bispectral Index of Patients of Thoracic Surgeries
May 17, 2020 updated by: Taipei Veterans General Hospital, Taiwan
Bispectral index(BIS) is commonly used to monitor the depth of anesthesia.
The electroencephalographic signal is collected and analyzed by the device, resulting a number related to the awareness of the patient.
Electromyography is also recorded.
The aim of the study is recording and analyzing the data of BIS and try to find it's relation to intraoperative neuromuscular blockade.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 112
- Department of Anesthesiology, Taipei Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing chest surgeries
Description
Inclusion Criteria:
- ASA class between 1 and 3
- Patients scheduled for chest surgery
Exclusion Criteria:
- Neuromuscular diseases
- Mental and psychiatric disturbance
- ASA class over 4
- Drug abuse
- Aboriginals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
BIS monitor group
Patients under monitoring of BIS
|
The BIS monitor will be attached to patients' forehead before anesthetized and kept until the end of the surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Establishing the predicting model of intraoperative electromyographics of BIS monitor and train-of-four of neuromuscular transmission monitor
Time Frame: six months
|
We will collect EMG activity of bispectral index and train-of-four/count of neuromuscular trasmission monitor in patients undergoing pulmonary surgeries.
Total intravenous anesthesia will be given to all included patients, and data will be collected since the induction of anesthesia until extubation of endotracheal tube.By statistical methods, we expect to establish the model predicting intraoperative neuromuscular blockade by EEG activity of BIS monitor.
|
six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2020
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
March 1, 2021
Study Registration Dates
First Submitted
March 3, 2020
First Submitted That Met QC Criteria
May 17, 2020
First Posted (Actual)
May 19, 2020
Study Record Updates
Last Update Posted (Actual)
May 19, 2020
Last Update Submitted That Met QC Criteria
May 17, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 2020-02-018AC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
No individual participant data will be shared to other researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.